Sana Biotechnology, Inc. Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted
Sana Biotechnology, Inc. (SANA) reported Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted of $749.00 thousand for the 3-month period ending 2021-06-30, per its 10-Q filed 2022-08-04.
Discontinued › Notes
us-gaap:UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted · last filed 2022-08-04
- Sana Biotechnology, Inc. undistributed earnings (loss) allocated to participating securities, diluted for the quarter ending 2021-06-30 was $749.00K.
| Period end | Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted 3 month |
|---|---|
| 2021-06-30 | $749.00K 10-Q · filed 2022-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Aura Biosciences, Inc. (AURA) | United States | $0.639B | -5.61 |